Back

Comparison of safety and benefits between single vs. dual antiplatelet therapy in patients undergoing transcatheter bioprosthetic aortic valve replacement: a meta-analysis

26 August 2018 (15:15 - 15:29)
Organised by:
Congress Presentation Part of: Maintenance of anti-thrombotic therapy after TAVI Aortic Valve Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Safeera Javed

Albert Einstein Medical Center, The Bronx (United States of America)

4 More presentations in this session

Presentation thumbnail
TAVI thrombosis - Current knowledge
Professor A. Finkelstein (Tel-Aviv, IL)
Slides Video
Presentation thumbnail
Type of oral anticoagulants and outcomes after transcatheter aortic valve implantation
Doctor D. Jochheim (Hattingen, DE)
Abstract Slides Video
Presentation thumbnail
Continued vs. interrupted oral anticoagulation in patients with atrial fibrillation undergoing transfemoral transcatheter aortiv valve implantation
Doctor N. Mangner (Dresden, DE)
Abstract
Presentation thumbnail
Anti-thrombotic therapy after TAVI - State of the art
Professor R. Kornowski (Petah Tikva, IL)
Slides Video

Access the full session

Session thumbnail
Maintenance of anti-thrombotic therapy after TAVI

The Event

Event poster

ESC Congress 2018

26 August 2018 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources